Drug
Sublingual Tablet
Sublingual Tablet is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_3
1
33%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
completed133%
unknown133%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic Requirements in Spine Surgery Patients
NCT04263909
unknownphase_3
Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia
NCT05456152
withdrawnnot_applicable
Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement
NCT05053308
Clinical Trials (3)
Showing 3 of 3 trials
NCT04263909Phase 4
The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic Requirements in Spine Surgery Patients
NCT05456152Phase 3
Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia
NCT05053308Not Applicable
Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3